Vktx Stock Forecast Zacks

Viking therapeutics has generated ($0.71) earnings per share over the last year ( ($0.71) diluted earnings per share). Vktx | complete viking therapeutics inc.

Merck Mrk Beats On Q3 Earnings Sales Ups 2021 View Nasdaq

This suggests a possible upside of 174.6% from the stock's current price.

Vktx stock forecast zacks. After reaching an important support level, viking therapeutics, inc. Shares of viking therapeutics, inc. Moreover, vktx currently has a zacks rank #2 (buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on.

Based on 1 wall street analysts offering 12 month price targets for bunge in the last 3 months. Viking therapeutics last posted its quarterly earnings data on november 3rd, 2021. Their forecasts range from $13.00 to $21.00.

In fact, when combining a zacks rank #3 or better and a positive earnings esp, stocks produced a positive surprise 70% of. Over the past four weeks, vktx has gained 8.5%. The company currently sits at a #2 (buy) on the zacks rank, also indicating that the stock could be poised for a breakout.

The highest, average, and lowest price. Based on 5 wall street analysts offering 12 month price targets for ngm biopharmaceuticals in the last 3 months. The average price target is $30.25 with a high forecast of $32.00 and a low forecast of $27.00.

(vktx) have gained 1.5% over the past four weeks to close the last trading session at $6.14, but there could still be. Management provides update on 2021 outlook. Find the latest viking therapeutics, inc.

Moreover, vktx currently has a zacks rank #2 (buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and eps surprises. The technique has proven to be very useful for finding positive surprises. Get the latest chart with broker recommendations from zacks investment research.

These stocks gained 30.7% in 2020 through december 14th and still beat the market by 15.8 percentage points. Zacks' 7 best strong buy stocks for december, 2021. The average price target is $15.00 with a high forecast of $18.00 and a low forecast of $13.00.

Analyst price target on bg. Nasdaq updated dec 4, 2021 12:51 am. Analyst price target on vktx.

The average price target represents a 17.66% change from the last price of $75.64. (nasdaq:vktx), including ceo brian lian, regarding the outlook for the company in. (vktx) could be a good stock pick from a technical perspective.

(vktx) stock quote, history, news and other vital information to help you with your stock trading and investing. Hedge funds were also right about betting on vktx as the stock returned 15.3% since the. The average price target is $89.00 with a high forecast of $89.00 and a low forecast of $89.00.

The average price target represents a 155.10% change from the last price of $5.88. Zacks' 7 best strong buy stocks for december, 2021. Based on 7 wall street analysts offering 12 month price targets for viking therapeutics in the last 3 months.

On average, they expect viking therapeutics' stock price to reach $15.57 in the next year. The biotechnology company reported ($0.17) eps for the quarter, beating the consensus estimate of ($0.21) by $0.04. We recently spoke to the management team at viking therapeutics, inc.

Multiple milestones upcoming in 2021 based on our probability adjusted dcf model that takes into account potential future revenues of vk5211, vk2809, and vk0214, vktx is valued at $22/share. The average price target represents a 36.88% change from the last price of $22.10. Which stocks will be december's top performers?

Roche Rhhby Gets Approval For Gavreto For Nsclc In Eu Nasdaq